Merck & Co., Inc. Marketable Securities (Non-Current)
Merck & Co., Inc. (MRK) had Marketable Securities (Non-Current) of $1.22 billion as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:MarketableSecuritiesNoncurrent · last filed 2026-08-07
- 2026-06-30: Marketable Securities, Noncurrent $1.22B.
- 2026-03-31: Marketable Securities, Noncurrent $1.10B.
- 2025-12-31: Marketable Securities, Noncurrent $956.00M.
- 2025-09-30: Marketable Securities, Noncurrent $1.12B.
| Period end | Marketable Securities, Noncurrent | Marketable Securities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $1.22B 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $1.10B 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $956.00M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $1.12B 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $774.00M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $616.00M 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $463.00M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $575.00M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $357.00M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $280.00M 10-Q · filed 2024-05-03 | |
| 2023-12-31 | $252.00M 10-K · filed 2025-02-25 | |
| 2023-09-30 | $1.31B 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $1.21B 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $1.29B 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $1.01B 10-K · filed 2024-02-26 | |
| 2022-09-30 | $984.00M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $238.00M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $316.00M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $370.00M 10-K · filed 2023-02-24 | |
| 2021-09-30 | $435.00M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $411.00M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $544.00M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $785.00M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $1.37B 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $1.25B 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $555.00M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $1.47B 10-K · filed 2021-02-25 | |
| 2019-09-30 | $2.11B 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $3.78B 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $5.62B 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $6.23B 10-K · filed 2020-02-26 | |
| 2018-09-30 | $7.61B 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $10.03B 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $11.03B 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $12.13B 10-K · filed 2019-02-27 | |
| 2017-09-30 | $12.21B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $12.14B 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $11.90B 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $11.42B 10-K · filed 2018-02-27 | |
| 2016-09-30 | $11.66B 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $11.88B 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $12.55B 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $13.04B 10-K · filed 2017-02-28 | |
| 2015-09-30 | $13.08B 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $13.33B 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $13.09B 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $13.52B 10-K · filed 2016-02-26 | |
| 2014-09-30 | $13.49B 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $12.62B 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $11.46B 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $9.77B 10-K · filed 2015-02-27 | |
| 2013-09-30 | $9.20B 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $8.55B 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $7.95B 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $7.30B 10-K · filed 2014-02-27 | |
| 2012-09-30 | $5.56B 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $4.08B 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $3.97B 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $3.46B 10-K · filed 2013-02-28 | |
| 2011-09-30 | $2.42B 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $2.17B 10-Q · filed 2011-08-08 | |
| 2011-03-31 | $2.08B 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $2.17B 10-K · filed 2012-02-28 | |
| 2010-09-30 | $2.14B 10-Q · filed 2010-11-08 | |
| 2010-06-30 | $2.05B 10-Q · filed 2010-08-06 | |
| 2010-03-31 | $2.00B 10-Q · filed 2010-05-07 | |
| 2009-12-31 | $432.00M 10-K · filed 2011-02-28 | $432.30M 10-K · filed 2010-03-01 |
| 2008-12-31 | $6.49B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |